Bharat Immunologicals Operating Margin

BIBCL -- India Stock  

INR 20.40  1.55  8.22%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Operating Margin Analysis

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Bharat Immunologicals 
Operating Margin 
 = 
Operating Income 
Revenue 
X
100 
 = 
4.32 %

About Operating Margin

A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Compare to competition
Based on recorded statements Bharat Immunologicals Biologicals Corp Ltd has Operating Margin of 4.32%. This is much higher than that of the Healthcare sector, and significantly higher than that of Operating Margin industry, The Operating Margin for all stocks is over 1000% lower than the firm.

Peer Comparison

Bharat Immunologicals Operating Margin Comparison
Bharat Immunologicals is currently under evaluation in operating margin category among related companies.

Did you try this?

Run Commodity Channel Index Now
   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Commodity Channel Index

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Fundamental Indicators

Current Bharat Immunologicals financial ratios